GLP Research Simplified
EZ PrepLabsPeptides
Menu +

Research reference

GLP-1 research and obesity statistics

A source-backed reference for researchers, writers, and anyone tracking the scale and direction of GLP-1 research. Updated November 13, 2026.

At a glance

Fourteen citable facts, with the source beside each one.

GLP-1 research sits within a wider landscape of metabolic research, public-health data, clinical evidence, and changing public use. The figures below are selected for clarity, traceability, and direct citation. Follow the linked source for its definitions, methods, and full context.

08

All but 1

U.S. states and territories with available 2025 data had adult obesity prevalence of at least 25%, except the District of Columbia.

The CDC reported that the District of Columbia had a 24.2% prevalence in 2025. This state and territory map is based on self-reported height and weight from the Behavioral Risk Factor Surveillance System.

Source: CDC, Adult Obesity Prevalence Maps, 2025 data, updated September 24, 2026 ↗

12

12%

of U.S. adults said they were currently taking a GLP-1 drug in late 2025.

KFF found that 18% of adults said they had ever taken this type of medication. These are self-reported survey results, not prescription totals.

Source: KFF Health Tracking Poll, November 14, 2025 ↗

Method and sources

How to use this reference.

Statistics are drawn from named public sources published by the World Health Organization, the U.S. Centers for Disease Control and Prevention, the U.S. Food and Drug Administration, KFF, and peer-reviewed clinical research. Each figure is presented with the source's own reporting period or publication date.

Definitions vary by source. For example, prevalence estimates use the source's stated age group, geography, and measurement method. Public-opinion figures are survey responses, while regulatory and population figures come from their respective agencies. This page is reviewed on a regular cadence, with stable statistic anchors retained for easy citation.

Suggested citation

GLP-123. “GLP-1 Research and Obesity Statistics.” Updated November 13, 2026. https://glp123peptides.com/glp-1-research-statistics